WASFI YASMINE enters SAVARA INC with 155K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 10/22/2025ACC: 0002092127-25-000002
Officer· Chief Medical Officer
Since Oct 2025
155K
Baseline shares
100% direct
155K
Direct ownership
1 position
285K
Derivative underlying
2 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned155K
Total
155K direct155K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 155K | Direct |
| Total | 155K | 155K direct |
Derivative Holdings2
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
110K
Shares owned
N/A
Exercise price
4.13
Expiration
—
Exercise window
—
Stock Option (Right to Buy)
DirectUnderlying security
Common Stock
Underlying shares
175K
Shares owned
N/A
Exercise price
3.35
Expiration
—
Exercise window
—
Total
Underlying
285K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock | 4.13 | — | — | 110K | N/A |
| Stock Option (Right to Buy) Direct | Common Stock | 3.35 | — | — | 175K | N/A |
| Total | 285K | 0.00 | ||||